Original contribution
Emergency department treatment of alcohol withdrawal seizures with phenytoin

https://doi.org/10.1016/S0196-0644(05)81606-3Get rights and content

Study objective:

Prevention of recurrent alcohol withdrawal seizures is a common emergency department problem. A prospective, randomized, placebo-controlled, double-blind study of adequate size was designed to assess the efficacy of phenytoin in preventing recurrence of alcohol withdrawal seizures.

Methods:

Fifty-five patients who had seized from alcohol withdrawal were randomly assigned to treatment with IV phenytoin or placebo. Patients with known seizure disorders and those receiving any anticonvulsant were excluded. The study was terminated after seizure recurrence or passage of a six-hour, high-risk seizure interval.

Results:

Six of 28 phenytoin-treated patients (21%) had recurrent seizures compared with five of 27 placebo-treated patients (19%). The 95% confidence interval for the difference in response probabilities was +16% to −20%. There was no statistically significant difference between the response rates for the two treatments (P > .05).

Conclusion:

Phenytoin does not show significant benefit over placebo in preventing recurrence of alcohol withdrawal seizures.

References (12)

There are more references available in the full text version of this article.

Cited by (53)

  • The role of group i mGlu receptors in the expression of ethanol-induced conditioned place preference and ethanol withdrawal seizures in rats

    2011, European Journal of Pharmacology
    Citation Excerpt :

    Although benzodiazepines and other positive modulators of GABAA receptors are commonly used for treatment of ethanol withdrawal seizures, they are relatively modestly active (Rogawski, 2005). Antiepileptic drugs, such as carbamazepine and phenytoine are also weak or ineffective in protecting against the ethanol withdrawal seizures (Barrons and Roberts, 2010; Bayard et al., 2004; Chance, 1991). Recently, Besheer et al. (2009) indicated that riluzole, a drug that inhibits NMDA and enhances GABAA receptor system, significantly decreased ethanol self-administration and the severity of handling-induced convulsions during ethanol withdrawal in mice.

  • Alcohol-Related Seizures

    2011, Emergency Medicine Clinics of North America
    Citation Excerpt :

    If CSF infection is a possibility, intravenous antibiotic therapy should be started, blood cultures obtained, and a lumbar puncture considered.36 Phenytoin has no significant benefit over placebo in preventing recurrence of AWS.1,37 Considering the risks of phenytoin and no demonstrated benefit in the setting of AWS, it is not indicated for the treatment of AWS.

  • Toxin-Related Seizures

    2011, Emergency Medicine Clinics of North America
  • Twenty per Hour: Altered Mental State Due to Ethanol Abuse and Withdrawal

    2010, Emergency Medicine Clinics of North America
    Citation Excerpt :

    Anticonvulsants such as phenytoin also have no role in ethanol withdrawal states (even withdrawal-related seizures), unless the patient has an underlying seizure disorder. This situation is sometimes seen when chronic ethanol abusers suffer head trauma and have epileptogenic foci, in which case anticonvulsants may be adjunct therapy to benzodiazepines in the emergency setting.122 There has been some evidence derived from ambulatory patients in Europe that carbamazepine is equal in efficacy to phenobarbital and oxazepam (the benzodiazepine used for comparison).

  • Alcohol and the Nervous System

    2008, Neurology and General Medicine
View all citing articles on Scopus
View full text